25^th European Pathology Congress

About the Conference

Call for Abstracts

We warmly invite researchers, clinicians, scientists, academicians, laboratory professionals, and healthcare experts to submit abstracts for presentation at the 25th European Pathology Congress. This is an excellent opportunity to present pioneering research, innovative diagnostic technologies, and impactful clinical case studies that are advancing the future of pathology, digital diagnostics, and precision healthcare.

Abstract Categories Include:

• Molecular Pathology and Genetic Diagnostics
• Digital Pathology and AI Applications
• Histopathology and Tissue-Based Studies
• Cytopathology and Fine-Needle Aspiration
• Oncopathology and Cancer Biomarkers
• Immunopathology and Immune Diagnostics
• Hematopathology and Blood Disorders
• Neuropathology and Brain Tumors
• Dermatopathology and Skin Lesions
• Infectious Disease Pathology
• Forensic and Legal Pathology
• Pediatric and Developmental Pathology
• Gastrointestinal and Hepatic Pathology
• Pulmonary and Thoracic Pathology
• Genitourinary and Renal Pathology
• Endocrine and Breast Pathology
• Cardiovascular Pathology
• Laboratory Medicine and Clinical Chemistry
• Global Health, Public Health, and Pandemic Pathology
• Rare Case Reports and Unique Diagnostic Challenges

Submission Guidelines:

• Abstracts must be written in English and structured with Background, Methods, Results, and Conclusion
• Word limit: 250–300 words
• All submissions must be original and unpublished at the time of submission
• You may select your preference for Oral Presentation, Poster Presentation, or Workshop Presentation
• Multiple submissions are welcome from individuals or research groups

Visa Information for Attendees

We warmly welcome all international participants to the 25th European Pathology Congress in Paris, France. To ensure a smooth and hassle-free travel experience, we strongly recommend that all attendees begin their visa application process as early as possible.

Do You Need a Visa to Enter France?

Participants from non-Schengen countries may require a short-stay Schengen visa to attend the congress. Please check with your nearest French Embassy or Consulate for the most accurate and updated requirements based on your nationality.

Steps to Apply for a Schengen Visa for France:

1. Check Visa Requirements:
   Visit the official France-Visas portal to determine your visa eligibility and required documents.
    
2. Gather Required Documents:
   • A valid passport (minimum 3 months validity beyond intended stay)
   • Completed visa application form
   • Proof of accommodation (hotel or congress booking)
   • Travel insurance
   • Flight itinerary
   • Invitation letter from the Congress Secretariat
   • Proof of financial means
      
3. Request Your Invitation Letter:
   After completing your registration for the congress, you may request an official invitation letter by contacting us at [email protected]. Please include your full name, passport number, and registration confirmation.
    
4. Schedule an Appointment:
   Book an appointment at your nearest French consulate or visa application center. Processing times may vary, so apply well in advance.
    
5. Attend the Visa Interview:
   Submit your application along with biometric data (fingerprints and photo). You may be asked to provide additional documentation.

Important Notes:

• The congress organizers are not authorized to intervene in visa applications but will support you with official documentation.
• Visa processing times can range from 15 to 30 working days depending on the location and season.
• Please ensure your visa covers the entire duration of your stay in the Schengen Area.

Need Assistance?

For any visa-related inquiries or help with your invitation letter, please reach out to our support team at [email protected].

We look forward to welcoming you to Paris for an engaging and impactful congress on AI, digital diagnostics, and precision care in the future of pathology!

Sessions & Tracks

Digital Pathology & AI in Diagnostics

Digital pathology is revolutionizing diagnostic workflows through whole-slide imaging, computational analysis, and AI-powered decision support. This track explores how artificial intelligence enhances diagnostic precision by automating image interpretation, identifying complex patterns, and improving biomarker quantification. Sessions will cover AI-assisted diagnostics, workflow optimization, regulatory challenges, and the integration of digital pathology into clinical practice. Discussions will also highlight the convergence of pathology with genomics and multi-omics data, advancing precision medicine and improving patient outcomes.

Molecular Pathology & Genomics

Molecular pathology plays a central role in precision medicine by enabling detailed analysis of genetic and molecular alterations in disease. This track focuses on cutting-edge technologies such as next-generation sequencing (NGS), liquid biopsy, and molecular profiling for disease diagnosis and monitoring. Sessions will address biomarker discovery, genomic diagnostics in oncology and inherited disorders, variant interpretation, and ethical considerations in genomic medicine. The track emphasizes translating molecular insights into targeted therapeutic strategies.

Precision Medicine & Targeted Therapies

Precision medicine depends on accurate pathological and molecular insights to guide individualized treatment strategies. This track explores biomarker-driven therapies, personalized oncology, immune-based treatments, and targeted drug development. Discussions will focus on therapy selection, resistance mechanisms, molecular tumor boards, and multidisciplinary collaboration. The track highlights innovations that bridge laboratory discoveries with clinical applications to improve treatment effectiveness and patient survival.

Cancer Pathology & Biomarkers

Advancements in cancer pathology are transforming diagnosis, prognosis, and therapeutic decision-making. This track focuses on morphological and molecular characterization of malignancies, novel biomarkers, and tumor subtyping. Topics include immunohistochemistry, molecular signatures, minimal residual disease monitoring, and AI-assisted biomarker scoring. Sessions emphasize improving diagnostic consistency and enabling personalized cancer treatment.

Infectious Disease Pathology & Emerging Pathogens

This track examines the pathological mechanisms of bacterial, viral, fungal, and parasitic diseases, with special focus on emerging infectious threats. Topics include histopathological features of infections, molecular diagnostics, antimicrobial resistance, and outbreak surveillance. Sessions highlight pathology’s role in public health preparedness, vaccine development, and global response to infectious diseases.

Immunopathology & Autoimmune Diseases

Immunopathology focuses on disorders caused by immune dysregulation, including autoimmune diseases and hypersensitivity reactions. This track covers advances in immunohistochemistry, biomarker discovery, and immune-related diagnostics. Sessions explore disease mechanisms, diagnostic tools, monitoring strategies, and therapeutic implications for autoimmune and inflammatory disorders.

Neuropathology & Neurodegenerative Disorders

This track explores the pathology of neurological diseases, including neurodegenerative disorders, brain tumors, inflammatory CNS conditions, and traumatic injuries. Sessions emphasize molecular diagnostics, immunohistochemistry, biomarker development, and AI-assisted analysis. The track highlights innovations that improve diagnostic accuracy and research in neurological diseases.

Pediatric & Developmental Pathology

Pediatric pathology addresses diseases unique to infants, children, and adolescents, including congenital abnormalities, developmental disorders, and pediatric tumors. This track focuses on molecular diagnostics, genetic syndromes, perinatal pathology, and ethical considerations in pediatric care. Discussions emphasize early diagnosis and personalized therapeutic approaches for improved outcomes.

Pulmonary & Thoracic Pathology

This track covers diseases affecting the lungs, pleura, and thoracic structures, including lung cancer, infections, and interstitial lung diseases. Sessions explore histopathological patterns, molecular biomarkers, targeted therapies, and digital pathology applications. Integration of radiological, clinical, and pathological data will be emphasized for comprehensive diagnosis.

Gastrointestinal & Liver Pathology

This track focuses on disorders of the gastrointestinal tract, liver, pancreas, and biliary system. Topics include inflammatory diseases, neoplasms, infectious conditions, and molecular diagnostics. Sessions will address standardized diagnostic criteria, biomarker-driven therapies, and the growing role of precision medicine in gastrointestinal and hepatic care.

Renal Pathology & Transplantation

Renal pathology provides critical insights into kidney disease diagnosis and transplant management. This track covers glomerular disorders, transplant rejection, immunofluorescence, and molecular diagnostic advances. Discussions focus on biomarkers for disease progression and personalized treatment strategies in nephrology.

Cardiovascular Pathology

This track examines pathological mechanisms underlying heart and vascular diseases such as cardiomyopathies, atherosclerosis, and vascular inflammation. Sessions highlight histopathology, biomarker research, molecular diagnostics, and digital pathology applications to improve cardiovascular disease characterization and treatment.

Hematopathology & Bone Marrow Diseases

Hematopathology focuses on diseases of blood, bone marrow, and lymphoid tissues, including leukemias, lymphomas, and myeloproliferative disorders. This track covers morphology, immunophenotyping, cytogenetics, molecular diagnostics, and minimal residual disease monitoring. AI and digital pathology applications in hematological diagnosis will also be explored.

Dermatopathology & Skin Cancers

This track addresses inflammatory skin disorders and skin malignancies such as melanoma and non-melanoma cancers. Sessions focus on histological interpretation, molecular profiling, biomarker development, and targeted therapies. Emerging diagnostic technologies and integration with clinical dermatology will be emphasized.

Women’s Health & Gynecologic Pathology

This track focuses on pathology of the female reproductive system, including gynecologic cancers and benign conditions. Topics include molecular classification, biomarker research, precision diagnostics, and standardized reporting. Sessions emphasize advances in minimally invasive diagnostics and personalized care in women’s health.

Digital Innovations in Laboratory Medicine

Digital transformation is reshaping laboratory medicine through automation, informatics, AI, and advanced analytics. This track explores workflow optimization, quality assurance, interoperability, data security, and intelligent decision support systems. Sessions highlight how digital innovation improves efficiency, accuracy, and patient-centered care.

Veterinary Pathology

Veterinary pathology examines diseases in animals and their implications for human health, including zoonotic diseases. This track covers infectious diseases, neoplasms, comparative pathology, and molecular diagnostics. The importance of the One Health approach in global disease surveillance will be highlighted.

Quality Control & Standardization in Pathology Labs

Maintaining high-quality standards is essential for reliable pathology services. This track addresses accreditation, regulatory compliance, laboratory quality assurance, and standardized diagnostic protocols. Sessions discuss improving reproducibility, reducing errors, and ensuring patient safety in pathology laboratories worldwide.

Translational Pathology: Bridging Research & Clinical Practice

Translational pathology connects laboratory discoveries with real-world clinical applications. This track focuses on biomarker validation, novel diagnostic technologies, therapeutic targets, and multidisciplinary collaboration. Sessions will showcase research that is directly transforming patient diagnosis and treatment.

Global Health & Pathology in Resource-Limited Settings

This track addresses challenges in delivering high-quality pathology services in low-resource environments. Topics include telepathology, affordable diagnostics, training programs, and healthcare capacity building. Discussions emphasize equitable access to advanced diagnostics and global collaboration to improve health outcomes worldwide.

Market Analysis

The global and European pathology markets are undergoing rapid transformation, driven by technological advancements in artificial intelligence (AI), digital diagnostics, molecular pathology, and precision medicine. These developments strongly align with the theme of the 25th European Pathology Congress, highlighting the growing importance of pathology in shaping the future of healthcare.

The European pathology services market has witnessed substantial growth in recent years and continues to expand due to the increasing burden of chronic and complex diseases such as cancer, cardiovascular disorders, neurological conditions, and diabetes. The growing demand for accurate, early, and personalized diagnosis is accelerating the adoption of advanced pathology solutions across hospitals, laboratories, and research institutions. Strong healthcare infrastructure, government funding for biomedical research, and supportive regulatory frameworks across Europe further contribute to market expansion.

One of the fastest-growing segments is digital pathology, which is revolutionizing traditional diagnostic workflows through whole-slide imaging, cloud-based collaboration, telepathology, and AI-assisted image analysis. Digital pathology improves diagnostic speed, enhances workflow efficiency, and enables remote consultations between specialists worldwide. The increasing integration of AI-driven tools for image interpretation, biomarker quantification, and predictive analytics is transforming pathology into a more precise and data-driven discipline.

The growing prevalence of cancer across Europe is another major market driver. Rising demand for early cancer detection, tumor classification, biomarker identification, and treatment response monitoring has increased the need for advanced pathological diagnostics. AI-powered systems are increasingly supporting pathologists in identifying subtle patterns, reducing diagnostic variability, and improving clinical decision-making.

Simultaneously, the precision medicine market in Europe continues to expand rapidly, fueled by breakthroughs in genomics, proteomics, biomarker research, personalized therapeutics, and big data analytics. Precision medicine relies heavily on pathology to provide detailed molecular and diagnostic insights that guide targeted treatment strategies. This shift from generalized treatment to individualized care is reshaping healthcare delivery and improving patient outcomes.

In addition, growing investments in automation, laboratory informatics, and integrated diagnostic platforms are enhancing laboratory productivity and enabling faster turnaround times. The convergence of pathology with computational sciences, machine learning, and multi-omics technologies is creating new opportunities for innovation across clinical diagnostics and biomedical research.

These evolving market trends reinforce the critical role of pathology in advancing AI-powered diagnostics and precision healthcare. As the field continues to evolve, the 25th European Pathology Congress serves as an essential platform for experts, researchers, and industry leaders to discuss emerging technologies, share groundbreaking research, and explore future opportunities in pathology and laboratory medicine.